| 查看: 1981 | 回复: 57 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 chu_mouse 的 3 个金币 ,回帖就立即获得 1 个金币,每人有 1 次机会 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
[交流]
清华药学院储凌课题组招聘有机化学、化学生物学、生物方向博后及研究助理
|
|||
|
About the PI Ling Chu was born and raised in Hefei, Anhui, China. He received a B.S. degree in Chemistry from the University of Science and Technology of China in 2012. He completed his Ph.D. study at the Scripps Research Institute, where he conducted research with Prof. Jin-Quan Yu on the development of Palladium-catalyzed C-H activation reactions. After completing his Ph.D. in 2017, he switched his research field to chemical biology and worked with Prof. Alanna Schepartz and Prof. Derek Toomre as a Brown-Coxe postdoctoral fellow at Yale School of Medicine. In the Schepartz/Toomre lab, he developed new chemical biology tools for two-color long-time lapse live-cell super-resolution imaging. He then joined Prof. Craig Crews’ lab in 2019 as a postdoctoral associate, where he led the development of first PROTAC capable of degrading oncogenic KRASG12C. Ling will join School of Pharmaceutical Sciences, Tsinghua University as an assistant professor in 2021. His research interest lies at the interface of chemistry and biology. Website: chu-lab.org Email: chu_lab@126.com About the research New chemical biology tools to explore the beyond-rule-of-5 drug space There is an increasing need to pursuit less druggable targets that offer high potential for the development of new therapeutic agents and may require beyond-rule-of-5 (bRo5) molecules in order to take advantage of these opportunities. Nevertheless, bRo5 chemical space remains relatively unexplored, most likely due to the perceived non-oral properties, increased complexity of compounds in this space and the synthetic chemistry challenges associated with its navigation. There is a pressing need to develop new technologies for the discovery and oral delivery of bRo5 drugs. We will develop new chemical biology approaches that enable phenotypic screening of large, de novo bRo5 compound libraries inside living cells. Such efforts could potentially yield novel hits for “undruggable” targets. The strategies used here will be further pursued for applications in oral delivery of bRo5 compounds. Affecting protein stability as a new strategy to target KRAS The Kirsten rat sarcoma viral oncogene homologue (KRAS) gene is one of the most frequently mutated oncogenes in cancer. KRAS is mutated in ~30% of human cancers and is one of the most sought-after targets for pharmacological modulation. Despite its well-recognized importance in cancer malignancy, continuous efforts in the past three decades failed to develop approved therapies for KRAS mutant cancer. Recent efforts in direct targeting KRASG12C have resulted in small molecule inhibitors that showed great promise in early clinical trials. However, G12C mutant only represents a small percentage of patients with oncogenic KRAS mutations. To explore a general strategy to target KRAS, we will combine chemical screen and genetic screen to identify small molecules and genes that can destabilize KRAS across different mutant KRAS cell lines. Results from these screens will provide novel therapeutic leads and mechanistic insights of KRAS degradation pathway. Leveraging these findings, we hope to develop next-gen small molecule therapeutics for the treatment of KRAS mutant cancer. New tools for live-cell protein labeling and super-resolution imaging Proteins are the essential components in cell function. To understand the function of proteins in living cells, it is important to know the properties of proteins in the temporal and spatial context of the cell. Currently, live-cell protein labeling and imaging technologies have several limitations: 1) Widely adopted tools for live-cell protein labeling have a large size (20-30kDa), giving rise to concerns that they may interfere with protein folding, trafficking, activity, and interactions; 2) Fluorescence proteins or small molecule dyes bleach quickly under super-resolution imaging conditions, thus prevent long-term protein imaging. To solve these problems, we will develop short peptide tags for site-specific protein labeling in live cells. Such tags contain only a few amino acids and will have minimal perturbation of protein function in live cells. We will also develop bleaching-resistant live cell protein imaging tools that allow biologists to visualize the dynamics of proteins at the nanoscopy level (resolution<50 nm) with unlimited “photon budget”. Training We are an interdisciplinary research group working at the interface of chemistry and biology. Students in the lab will receive multidisciplinary training in experimental techniques ranging from synthetic chemistry to fluorescence microscopy to cellular studies. Representative skill sets in the group are given below. Chemical tools: organic synthesis, catalysts, medicinal chemistry, peptide synthesis Cell culture: mammalian cell lines, primary cell cultures Cell imaging: Confocal microscopy, STED, single-molecule microscopy, flow cytometry Molecular biology: Cloning, PCR, CRISPR Biochemistry: Protein purification, western blotting About the job We are actively recruiting. If you are passionate about chemical biology and drug discovery, come join us! Don’t hesitate to reach out to Dr. Chu at chu_lab@126.com Postdoc positions in biology Candidates should hold a PhD degree in cell biology, biochemistry, chemical biology, pharmacology or related fields. Experiences in phenotypic high-throughput assay or CRISPR screen are preferred but not required. If you are interested in joining the lab, please send your CV, research summary, and contact information of three referees to Dr. Chu at chu_lab@126.com. Postdoc positions in chemistry Candidates should hold a PhD degree in organic chemistry, medicinal chemistry or related fields. Experiences in transition-metal catalysts are preferred but not required. If you are interested in joining the lab, please send your CV, research summary, and contact information of three referees to Dr. Chu at chu_lab@126.com. Research assistants/Technicians Candidates should hold an MS or BS degree in chemistry or biology. If you are interested in joining the lab, please send your CV and contact information of three referees to Dr. Chu at chu_lab@126.com. Competitive salaries will be provided for qualified applicants. [ Last edited by chu_mouse on 2020-11-1 at 02:29 ] |
» 猜你喜欢
化学调剂0703
已经有6人回复
求老师收留调剂
已经有4人回复
268求调剂
已经有6人回复
283求调剂
已经有9人回复
085600材料与化工 求调剂
已经有12人回复
288求调剂
已经有3人回复
309求调剂
已经有4人回复
080500,材料学硕302分求调剂学校
已经有5人回复
304求调剂
已经有5人回复
复试调剂
已经有11人回复
» 抢金币啦!回帖就可以得到:
【武汉高校】【新能源材料与器件课题组】 招收优秀硕士调剂生!!!
+5/120
物理学 调剂
+1/88
物理学 调剂
+1/87
招收调剂生,动物医学、水产养殖、水产动物医学等专业
+1/86
招收苏州国家实验室和苏州大学联合培养博士(2026年9月入学)
+1/83
找工作经验求助
+1/39
0854电子信息调剂,集成电路,芯片方向,闽南师范大学光电芯片研发实验室
+1/39
欢迎报读澳门大学中药机制与质量研究全国重点实验室硕士研究生
+1/38
中科院化学所 宋延林 课题组招聘合成化学方向博士后(开展打印合成化学方向研究)
+1/33
山东省植物基蛋白技术创新中心课题组联合培养硕士研究生招募启事
+1/17
英国埃克塞特大学 & 法国巴黎萨克雷大学联合培养博士
+1/9
重庆大学诚招2026年生物材料方向博士生
+1/8
哈尔滨理工大学材料与化学工程学院 纳米功能材料与光电催化团队 招收硕士研究生
+1/8
重庆大学诚招2026年生物材料方向博士生
+1/5
上海第二工业大学-朱大海课题组招生(过线就能调剂)
+1/5
福建师范大学化学与材料学院杜克钊团队招生
+1/2
海南大学徐月山老师招生第二批博士名额2~3个,2026年9月份入学(高端设备开发方向)
+1/2
徐工-环境工程学院-招收调剂硕士
+1/1
矿业工程招收硕士研究生
+1/1
南方科技大学生命科学学院基础免疫与微生物学系招收博士后
+1/1
15楼2020-10-30 08:02:10
简单回复
tzynew3楼
2020-10-29 11:12
回复
chu_mouse(金币+1): 谢谢参与
8 发自小木虫Android客户端
tzynew4楼
2020-10-29 11:12
回复
tzynew5楼
2020-10-29 11:12
回复
encryption13楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
ro1114楼
2020-10-29 12:50
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
howtoge8楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
icanspll7楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
zzhello11楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
likecitywo12楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
yaqianye9楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
shehuifei10楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
TTTiger2楼
2020-10-29 10:55
回复
chu_mouse(金币+1): 谢谢参与
好 发自小木虫IOS客户端













回复此楼